These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 21839501)

  • 1. T-cell involvement in delayed-type hypersensitivity reactions to infliximab.
    Torres MJ; Chaves P; Doña I; Blanca-López N; Canto G; Mayorga C; Blanca M
    J Allergy Clin Immunol; 2011 Dec; 128(6):1365-1367.e1. PubMed ID: 21839501
    [No Abstract]   [Full Text] [Related]  

  • 2. T cell assessment in allergic drug reactions during the acute phase according to the time of occurrence.
    Torres MJ; Mayorga C; Fernández TD; Cornejo-García JA; Antúnez C; Valenzuela M; Del Prado MF; Rodriguez-Pena R; Blanca M
    Int J Immunopathol Pharmacol; 2006; 19(1):119-30. PubMed ID: 16569350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha receptor: Fc fusion protein.
    Zeltser R; Valle L; Tanck C; Holyst MM; Ritchlin C; Gaspari AA
    Arch Dermatol; 2001 Jul; 137(7):893-9. PubMed ID: 11453808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin testing and infliximab-specific antibodies detection as a combined strategy for preventing infusion reaction.
    Vultaggio A; Matucci A; Nencini F; Pratesi S; Maggi E
    Intern Emerg Med; 2012 Sep; 7 Suppl 2():S77-9. PubMed ID: 21544533
    [No Abstract]   [Full Text] [Related]  

  • 5. Management and preparedness for infusion and hypersensitivity reactions.
    Lenz HJ
    Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed hypersensitivity reaction after initial dose of infliximab: a case report.
    Krajcovicova A; Hlavaty T; Zelinkova Z; Letkovsky J; Huorka M
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):485-7. PubMed ID: 24509644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-T cell monoclonal antibodies in vivo. I. Inhibition of delayed hypersensitivity but not cutaneous basophil hypersensitivity reactions.
    Sobel RA; Hanzakos JL; Blanchette BW; Williams AM; Dellapelle P; Colvin RB
    J Immunol; 1987 Apr; 138(8):2500-6. PubMed ID: 3494071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD69 upregulation on T cells as an in vitro marker for delayed-type drug hypersensitivity.
    Beeler A; Zaccaria L; Kawabata T; Gerber BO; Pichler WJ
    Allergy; 2008 Feb; 63(2):181-8. PubMed ID: 18005225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Technics for the experimental study of delayed hypersensitivity].
    Lamarche M
    Ann Anesthesiol Fr; 1976; 17(3):371-7. PubMed ID: 10786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-lasting reactivity and high frequency of drug-specific T cells after severe systemic drug hypersensitivity reactions.
    Beeler A; Engler O; Gerber BO; Pichler WJ
    J Allergy Clin Immunol; 2006 Feb; 117(2):455-62. PubMed ID: 16461148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity.
    Schmid DA; Depta JP; Pichler WJ
    Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential involvement of dendritic cells in delayed-type hypersensitivity reactions to beta-lactams.
    Rodriguez-Pena R; Lopez S; Mayorga C; Antunez C; Fernandez TD; Torres MJ; Blanca M
    J Allergy Clin Immunol; 2006 Oct; 118(4):949-56. PubMed ID: 17030251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro methods for diagnosing nonimmediate hypersensitivity reactions to drugs.
    Mayorga C; Sanz ML; Gamboa P; Garcia-Aviles MC; Fernandez J; Torres MJ; ; ;
    J Investig Allergol Clin Immunol; 2013; 23(4):213-25; quiz precedeing 225. PubMed ID: 23964550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delayed drug hypersensitivity reactions - new concepts.
    Posadas SJ; Pichler WJ
    Clin Exp Allergy; 2007 Jul; 37(7):989-99. PubMed ID: 17581192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of leprosy and type 1 leprosy reactions after treatment with infliximab: a report of 2 cases.
    Scollard DM; Joyce MP; Gillis TP
    Clin Infect Dis; 2006 Jul; 43(2):e19-22. PubMed ID: 16779736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Very late delayed-allergic reaction to natalizumab not associated with neutralizing antibodies.
    Killestein J; Jasperse B; Liedorp M; Seewann A; Polman Ch
    Mult Scler; 2009 Apr; 15(4):525-6. PubMed ID: 19324985
    [No Abstract]   [Full Text] [Related]  

  • 17. [Delayed hypersensitivity as a result of successful chemotherapy of neoplasms].
    Jedrzejczak WW
    Wiad Lek; 1980 Apr; 33(7):547-53. PubMed ID: 6967240
    [No Abstract]   [Full Text] [Related]  

  • 18. Vegetating iododerma. An immunologic mechanism.
    Rosenberg FR; Einbinder J; Walzer RA; Nelson CT
    Arch Dermatol; 1972 Jun; 105(6):900-5. PubMed ID: 4260541
    [No Abstract]   [Full Text] [Related]  

  • 19. T cell-mediated reactions to iodinated contrast media: evaluation by skin and lymphocyte activation tests.
    Kanny G; Pichler W; Morisset M; Franck P; Marie B; Kohler C; Renaudin JM; Beaudouin E; Laudy JS; Moneret-Vautrin DA
    J Allergy Clin Immunol; 2005 Jan; 115(1):179-85. PubMed ID: 15637566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro tests in drug hypersensitivity diagnosis.
    Lochmatter P; Zawodniak A; Pichler WJ
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):537-54. PubMed ID: 19563996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.